FDA MedWatch: Voluntary Nationwide Recall of Hydrochlorothiazide Tablets USP 12.5 Mg Due to Labeling Mix-up

August 30, 2018

Accord Healthcare Inc. is voluntarily recalling One lot (Lot PW05264 – 46632 Bottles, NDC 16729-182-01) of Hydrochlorothiazide Tablets USP, 12.5 mg, to the consumer level.

FDA MedWatch Class 2 Device Recall: AMIA Automated PD Cycler

Date Initiated by Firm

July 12, 2018

Create Date

August 02, 2018

FDA MedWatch: AuroMedics Pharma LLC Issues Voluntary Nationwide Recall of Piperacillin and Tazobactam

August 1, 2018

Hospira Issues Voluntary Nationwide Recall of Daptomycin for Injection Lyophilized Powder for Solution, Due to Infusion Reactions

Hospira Issues Voluntary Nationwide Recall of Daptomycin for Injection Lyophilized Powder for Solution, Due to Infusion Reactions

Fluoroquinolone Antibiotics: FDA Requires Labeling Changes

ISSUE: FDA is strengthening the current warnings in the prescribing information that fluoroquinolone antibiotics may cause significant decreases in blood sugar and certain mental health side effects. 

CDC Health Advisory: Outbreak of Hepatitis A Virus (HAV) Infections among Persons Who Use Drugs and Persons Experiencing Homelessness

June 11, 208

Original content : https://emergency.cdc.gov/han/han00412.asp

Apotex Corp. Issues Voluntary Nationwide Recall of Piperacillin and Tazobactam For Injection

May 14, 2018

Ampicillin and Sulbactam for Injection USP, 3 g Single-Dose Vials by AuroMedics Pharma: Recall - Presence of Red Particulate Matter

May 8, 2018

Piperacillin and Tazobactam for Injection, USP 3.375 g Vials by AuroMedics Pharma: Recall - Vials Contain Particulate Matter

May 8, 2018

Pages